Skip Navigation

VAERS Bibliography - November 2003

  1. Public Health and Aging: Influenza Vaccination Coverage Among Adults Aged > or =50 Years and Pneumococcal Vaccination Coverage Among Adults Aged > or =65 Years--United States, 2002.   MMWR Morb.Mortal.Wkly.Rep.  52 (41): 987-992; October 17, 2003.

  2. Measles Epidemic Attributed to Inadequate Vaccination Coverage--Campania, Italy, 2002.   MMWR Morb.Mortal.Wkly.Rep.  52 (43): 1044-1047; October 31, 2003.

  3. Standards for Child and Adolescent Immunization Practices. National Vaccine Advisory Committee.   Pediatrics.  112 (4): 958-963; October, 2003.

  4. A Position Statement on Smallpox Vaccination Programs.   J Perianesth.Nurs.  18 (5): 305-306; October, 2003.

  5. Poliomyelitis Vaccination for International Travellers.   Can Commun Dis Rep.  29:1-7. (): 1-7; October 15, 2003.

  6. Racial/Ethnic Disparities in Influenza and Pneumococcal Vaccination Levels Among Persons Aged > or =65 Years--United States, 1989-2001.   MMWR Morb.Mortal.Wkly.Rep.  52 (40): 958-962; October 10, 2003.

  7. The 1971 Smallpox Outbreak in the Soviet City of Aralsk: Implications for Variola Virus As a Bioterrorist Threat. Proceedings of Special Issue.   Crit Rev Microbiol.  29 (2): 79-190; 2003.

  8. National Briefing: Science and Health--Influenza Vaccine Supply Expected to Meet Demand, CDC Recommends Influenza Vaccinations Begin in October.   J Miss.State Med Assoc.  44 (8): 266-267; August, 2003.

  9. Cardiac Deaths After a Mass Smallpox Vaccination Campaign--New York City, 1947.  MMWR Morb.Mortal.Wkly.Rep.  52 (39): 933-936; October 3, 2003.

  10. Adamkiewicz, T. V.; Sarnaik, S.; Buchanan, G. R.; Iyer, R. V.; Miller, S. T.; Pegelow, C. H.; Rogers, Z. R.; Vichinsky, E.; Elliott, J.; Facklam, R. R.; O'brien, K. L.; Schwartz, B.; Van Beneden, C. A.; Cannon, M. J.; Eckman, J. R.; Keyserling, H.; Sullivan, K.; Wong, W. Y.; Wang, W. C.  Invasive Pneumococcal Infections in Children With Sickle Cell Disease in the Era of Penicillin Prophylaxis, Antibiotic Resistance, and 23-Valent Pneumococcal Polysaccharide Vaccination.   J Pediatr.  143 (4): 438-444; October, 2003.

  11. Ahmad, K.  WHO Steps Up Fight Against Poliomyelitis.   Lancet Neurol.  2 (10): 586; October, 2003.

  12. Aragon, T. J.; Fernyak, S. E.  The Risks and Benefits of Pre-Event Smallpox Vaccination: Where You Stand Depends on Where You Sit.   Ann Emerg.Med.  42 (5): 681-684; November, 2003.

  13. Asikainen, T.; Giesecke, J.; Svensson, A.  [Measles Takes Root in Sweden Again. Reduced Vaccination Will Result in Epidemics, About 25 000 Cases Are Expected to Occur Annually Within a 15-Year Period].   Lakartidningen.  100 (40): 3126-3130; October 2, 2003.

  14. Barbero, Gonzalez A.; Alvarez de Toledo, Saavedra F.; Esteban, Fernandez J.; Pastor-Sanchez, R.; Gil, de Miguel; Rodriguez Barrios, J. M.; Garcia, Cebrian F.; Capdevilla, Prim C.  [Management of Vaccinations and Prophylaxis of International Travellers From Community Pharmacy (VINTAF Study)].   Aten.Primaria.  32 (5): 276-281; September 30, 2003.

  15. Boran, C.; Coban, Y. K.; Sasmaz, S.; Parmaksiz, G.   Huge Keloid Formation After BCG Vaccination.   Pediatr Dermatol.  20 (5): 460; September, 2003.

  16. Daly, A. D.; Nxumalo, M. P.; Biellik, R. J.  Missed Opportunities for Vaccination in Health Facilities in Swaziland.   S Afr Med J.  93 (8): 606-610; August, 2003.

  17. Darling, R. G.; Waeckerle, J. F.; Grabenstein, C. O.; Koenig, K. L.  Removing Health Care Workers From Clinical Duties After Smallpox Vaccination: Is It Really Necessary?   Ann Emerg.Med.  42 (5): 685-688; November, 2003.

  18. Dasgupta, S.; Bhinge, A.; Chandran, V.; Sewlikar, S.; Nimbkar, A.; Datta, D.  Role of L-Lysine HCl in Immunopotentiation Towards Development of Suitable Tuberculosis Vaccination.   Vaccine.  21 (32): 4722-4727; December 1, 2003.

  19. Delhaye, M.; Clavreul, A.; Garcion, E.; Menei, P.  [Anti-Glioma Vaccination].   Neurochirurgie.  49 (4): 459-463; September, 2003.

  20. Eichner, M.  Analysis of Historical Data Suggests Long-Lasting Protective Effects of Smallpox Vaccination.   Am J Epidemiol.  158 (8): 717-723; October 15, 2003.

  21. Fredette, M. J.; De Serres, G.; Malenfant, M.  Ophthalmological and Biological Features of the Oculorespiratory Syndrome After Influenza Vaccination.   Clin Infect Dis.  37 (8): 1136-1138; October 15, 2003.

  22. Garcia-Moll, X.  Influenza Vaccination: a New Indication of an Old Therapy?   Rev Esp.Cardiol.  56 (10): 944-946; October, 2003.

  23. Glaser, R.; Robles, T. F.; Sheridan, J.; Malarkey, W. B.; Kiecolt-Glaser, J. K.  Mild Depressive Symptoms Are Associated With Amplified and Prolonged Inflammatory Responses After Influenza Virus Vaccination in Older Adults.   Arch Gen.Psychiatry.  60 (10): 1009-1014; October, 2003.

  24. Gruchalla, R. S.; Jones, J.  Combating High-Priority Biological Agents: What to Do With Drug-Allergic Patients and Those for Whom Vaccination Is Contraindicated?   J Allergy Clin Immunol.  112 (4): 675-682; October, 2003.

  25. Harper, S. A.; Fukuda, K.; Cox, N. J.; Bridges, C. B.  Using Live, Attenuated Influenza Vaccine for Prevention and Control of Influenza: Supplemental Recommendations of the Advisory Committee on Immunization Practices (ACIP).   MMWR Recomm.Rep.  52 (RR-13): 1-8; September 26, 2003.

  26. Hassler, D.; Braun, R.  [When Should Vaccination of Phenprocoumon Patients Take Place?].   Dtsch Med Wochenschr.  128 (36): 1854; September 5, 2003.

  27. Herzog, N. S.; Bratzler, D. W.; Houck, P. M.; Jiang, H.; Nsa, W.; Shook, C.; Weingarten, S. R.  Effects of Previous Influenza Vaccination on Subsequent Readmission and Mortality in Elderly Patients Hospitalized With Pneumonia.   Am J Med.  115 (6): 454-461; October 15, 2003.

  28. Janda, J.; Skovrankova, J.  [What Did the Campaigns Against Childhood Vaccination Accomplish in Developed Countries?].   Cas Lek Cesk.  142 (7): 437-441; 2003.

  29. Kawai, N.; Ikematsu, H.; Iwaki, N.; Satoh, I.; Kawashima, T.; Tsuchimoto, T.; Kashiwagi, S.  A Prospective, Internet-Based Study of the Effectiveness and Safety of Influenza Vaccination in the 2001-2002 Influenza Season.   Vaccine.  21 (31): 4507-4513; November 7, 2003.

  30. Kobayashi, M.; Hirakawa, K.; Sawada, M.; Suzuki, C.; Saikawa, S.; Ando, H.; Nakane, M.; Nakano, T.  Vaccination Coverage of Poliomyelitis Among Less Than 5-Year-Old Children in the Markets of Niger.   Jpn.J Infect Dis.  56 (4): 175-177; August, 2003.

  31. Kohrt, A. E.  Child and Adolescent Immunizations: New Recommendations, New Standards, New Opportunities.   Pediatrics.  112 (4): 978-981; October, 2003.

  32. Kyaw, M. H.; Christie, P.; Clarke, S. C.; Mooney, J. D.; Ahmed, S.; Jones, I. G.; Campbell, H.  Invasive Pneumococcal Disease in Scotland, 1999-2001: Use of Record Linkage to Explore Associations Between Patients and Disease in Relation to Future Vaccination Policy.   Clin Infect Dis.  37 (10): 1283-1291; November 15, 2003.

  33. Landi, F.; Onder, G.; Cesari, M.; Gravina, E. M.; Lattanzio, F.; Russo, A.; Bernabei, R.  Effects of Influenza Vaccination on Mortality Among Frail, Community-Living Elderly Patients: an Observational Study.   Aging Clin Exp Res.  15 (3): 254-258; June, 2003.

  34. Lee, P. P.  Prevention and Control of Influenza.   South Med J.  96 (8): 751-757; August, 2003.

  35. 35. Leon, De La Fuente; Gurfinkel, E. P.; Toledo, D.; Mautner, B.  Flu Vaccination in Patients With Acute Coronary Syndromes: Treatment Benefit in Prespecified Subgroups.   Rev Esp.Cardiol.  56 (10): 949-954; October, 2003.

  36. Long, S. S.  Smallpox Vaccination and Pregnancy.   J Pediatr.  143 (4): 476; October, 2003.

  37. Mercier, E.; Serie, M.; Gissot, V.; Dequin, P. F.  [Tetanus Vaccination. Re-Vaccination Is Necessary but Not Always Sufficient].   Presse Med.  32 (30): 1418; September, 2003.

  38. Minor, P. D.  Poliovirus Vaccination: Current Understanding of Poliovirus Interactions in Humans and Implications for the Eradication of Poliomyelitis.   Expert.Rev Mol.Med.  1:1-17. (): 1-17; September 23, 1999.

  39. Moorthy, V. S.; Pinder, M.; Reece, W. H.; Watkins, K.; Atabani, S.; Hannan, C.; Bojang, K.; McAdam, K. P.; Schneider, J.; Gilbert, S.; Hill, A. V.  Safety and Immunogenicity of DNA/Modified Vaccinia Virus Ankara Malaria Vaccination in African Adults.   J Infect Dis.  188 (8): 1239-1244; October 15, 2003.

  40. Mossong, J.; Muller, C. P.  Modelling Measles Re-Emergence As a Result of Waning of Immunity in Vaccinated Populations.    Vaccine.  21 (31): 4597-4603; November 7, 2003.

  41. Muniz, A. E.  Lymphocytic Vasculitis Associated With the Anthrax Vaccine: Case Report and Review of Anthrax Vaccination.   J Emerg.Med.  25 (3): 271-276; October, 2003.

  42. Murphy, J. G.; Wright, R. S.; Bruce, G. K.; Baddour, L. M.; Farrell, M. A.; Edwards, W. D.; Kita, H.; Cooper, L. T.  Eosinophilic-Lymphocytic Myocarditis After Smallpox Vaccination.   Lancet.  362 (9393): 1378-1380; October 25, 2003.

  43. Murray, C. J.; Shengelia, B.; Gupta, N.; Moussavi, S.; Tandon, A.; Thieren, M.  Validity of Reported Vaccination Coverage in 45 Countries.   Lancet.  362 (9389): 1022-1027; September 27, 2003.

  44. Muszkat, M.; Friedman, G.; Dannenberg, H. D.; Greenbaum, E.; Lipo, M.; Heymann, Y.; Zakay-Rones, Z.; Ben Yehuda, A.  Response to Influenza Vaccination in Community and in Nursing Home Residing Elderly: Relation to Clinical Factors.   Exp Gerontol.  38 (10): 1199-1203; October, 2003.

  45. Nass, M.  Safety of the Smallpox Vaccine Among Military Recipients.   JAMA.  290 (16): 2123-2124; October 22, 2003.

  46. Norrby, R.; Tull, P.  [Receding Adherence to Child Vaccination Programs Must Be Interrupted. Take Parents' Anxiety Seriously, Establish Regional Vaccination Centers].   Lakartidningen.  100 (40): 3110-3111; October 2, 2003.

  47. Pastor Climent, M. A.; Schwarz, Chavarri H.; Pedrera, Carbonell, V; Pascual, De La Torre  [Anti-Flu Vaccination in Health Staff: Problem of Consciousness-Raising or of Conscience?]. Aten.Primaria.  32 (6): 395-396; October 15, 2003.

  48. Perez, E. E.; Bokszczanin, A.; McDonald-McGinn, D.; Zackai, E. H.; Sullivan, K. E.  Safety of Live Viral Vaccines in Patients With Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome/Velocardiofacial Syndrome).   Pediatrics.  112 (4): e325; October, 2003.

  49. Plaut, M.; Tinkle, S. S.  Risks of Smallpox Vaccination: 200 Years After Jenner.   J Allergy Clin Immunol.  112 (4): 683-685; October, 2003.

  50. Prier, J. E.; Prier, S. G.  Believe Epidemiology Key to Vaccination Protocols.   J Am Vet.Med Assoc.  223 (7): 948-949; October 1, 2003.

  51. Roberts, R. J.  Tuberculin Testing Before BCG Vaccination: Effect of Age on Adverse Effects Has Not Been Made Clear.   BMJ.  327 (7420): 932; October 18, 2003.

  52. Samuelsson, K.; Blennow, M.  [Parents Rely on Child Vaccinations. But at the Same Time They Distrust the Medical Establishment As Shown in a Qualitative Study of Attitudes].   Lakartidningen.  100 (40): 3132-3135; October 2, 2003.

  53. Santiago, E. M.; Lawson, E.; Gillenwater, K.; Kalangi, S.; Lescano, A. G.; Du, Quella G.; Cummings, K.; Cabrera, L.; Torres, C.; Gilman, R. H.  A Prospective Study of Bacillus Calmette-Guerin Scar Formation and Tuberculin Skin Test Reactivity in Infants in Lima, Peru.   Pediatrics.  112 (4): e298; October, 2003.

  54. Sanz, J. C.; Fernandez, M.; Sagues, M. J.; Ramirez, R.  [Laboratory Diagnosis of Parotiditis in the Post-Vaccination Era: New Strategies].   Enferm.Infecc.Microbiol Clin.  21 (7): 383-384; August, 2003.

  55. Skowronski, D. M.; De Serres, G.; Scheifele, D.; Russell, M. L.; Warrington, R.; Davies, H. D.; Dionne, M.; Duval, B.; Kellner, J.; MacDonald, J.  Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Rate of Recurrence of Oculorespiratory Syndrome Following Influenza Vaccination Among Persons Previously Affected.   Clin Infect Dis.  37 (8): 1059-1066; October 15, 2003.

  56. Szilagyi, P. G.; Iwane, M. K.; Schaffer, S.; Humiston, S. G.; Barth, R.; McInerny, T.; Shone, L.; Schwartz, B.  Potential Burden of Universal Influenza Vaccination of Young Children on Visits to Primary Care Practices.   Pediatrics.  112 (4): 821-828; October, 2003.

  57. Terada, K.; Niizuma, T.; Ogita, S.; Kataoka, N.  [Survey of the Past History of Measles and Rubella and Advocacy for Vaccination and Certificates of Vaccination at Entry to Kindergarten, Primary School and Junior High School in Kurashiki City--to Improve the Vaccination Rate].   Kansenshogaku Zasshi.  77 (9): 667-672; September, 2003.

  58. Thorne, C. D.; Hirshon, J. M.; Himes, C. D.; McDiarmid, M. A.  Emergency Medicine Tools to Manage Smallpox (Vaccinia) Vaccination Complications: Clinical Practice Guideline and Policies and Procedures.   Ann Emerg.Med.  42 (5): 665-680; November, 2003.

  59. Wood, D. L.  Increasing Immunization Coverage. American Academy of Pediatrics Committee on Community Health Services. American Academy of Pediatrics Committee on Practice and Ambulatory Medicine.   Pediatrics.  112 (4): 993-996; October, 2003.

  60. Zielinski, A.; Kwon, C. B.; Tomaszunas-Blaszczyk, J.; Magdzik, W.; Bennett, J. V.  Risk of Haemophilus Influenzae Type b Meningitis in Polish Children Varies Directly With Number of Siblings: Possible Implications for Vaccination Strategies.   Eur J Epidemiol.  18 (9): 917-922; 2003.

  61. Zimmerman, R. K.; Nowalk, M. P.; Raymund, M.; Tabbarah, M.; Hall, D. G.; Wahrenberger, J. T.; Wilson, S. A.; Ricci, E. M.  Tailored Interventions to Increase Influenza Vaccination in Neighborhood Health Centers Serving the Disadvantaged.   Am J Public Health.  93 (10): 1699-1705; October, 2003.

[top]